Patent · US Active

Pharmaceutical composition

US9492406B2 · kind B2 · utility

2Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2013
Grant dateNov 15, 2016
Priority date
Expiry dateSep 20, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a novel pharmaceutical composition having enhanced bioavailability through improved aqueous dissolution of poorly water soluble drugs, and to a method for preparing it. The invention more particularly relates to an oral pharmaceutical composition containing active ingredients of poor aqueous solubility, more specifically, antiparasitic and antipneumocystic drug Atovaquone alone or in combination with Proguanil.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.